Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318985A2 4-amino-quinazolines
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318982A1 Compounds and methods for diagnosing and treating amyloid-related conditions
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
06/18/2003EP1318837A2 Method of treating estrogen receptor positive carcinoma
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318821A1 Fluid for haemofiltration
06/18/2003EP1318820A2 Xenon as medicament
06/18/2003EP1318819A1 Treatment of trauma, and other indications
06/18/2003EP1318818A1 Diphosphonate solutions
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318815A2 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318813A1 Stable pergolide mesylate and process for making same
06/18/2003EP1318812A1 Methods for delaying recurrence of herpes virus symptoms
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1318810A1 Manzamines for treatment of drug resistant infection
06/18/2003EP1318809A1 Micronized torsemide
06/18/2003EP1318808A1 Method of treating aquatic animals with an antimicrobial agent and chelating agent
06/18/2003EP1318807A1 Photosensitizing ointment
06/18/2003EP1318806A1 Fatty acid synthase inhibitors
06/18/2003EP1318805A2 Pharmaceutical composition containing citalopram
06/18/2003EP1318804A1 Iron compositions
06/18/2003EP1318803A1 Fatty acid synthase inhibitors
06/18/2003EP1318802A2 Substituted hydrazine derivatives
06/18/2003EP1318801A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same
06/18/2003EP1318800A1 1-amino-alkylcyclohexanes as trypanocidal agents
06/18/2003EP1318799A2 Stable dosage forms containing ubiquinones
06/18/2003EP1318798A1 Water-soluble prodrugs of propofol for treatment of migraine
06/18/2003EP1318797A1 Volatile anaesthetic with xenon
06/18/2003EP1318796A2 Polynucleotide intercalator interceptors and inhibitors
06/18/2003EP1318795A2 Anthelmintics for preventing parasitic infections in humans and animals
06/18/2003EP1318794A2 Method for reducing toxicity of combined chemotherapies
06/18/2003EP1318792A2 Sustained release composition containing clarithromycin
06/18/2003EP1318791A1 Pharmaceutical semi-solid composition of isotretinoin
06/18/2003EP1318788A1 Solid dose nanoparticulate compositions
06/18/2003EP1318787A2 Pharmaceutical suspension compositions lacking a polymeric suspending agent
06/18/2003EP1318785A2 Pulmonary delivery in treating disorders of the central nervous system
06/18/2003EP1318784A1 Composition of vitamin c and/or vitamin a
06/18/2003EP1318761A1 Concurrent tooth repositioning and substance delivery
06/18/2003EP1318725A2 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
06/18/2003EP1318721A1 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions
06/18/2003EP1275377B1 Granulates containing liposoluble substances and process of preparation thereof
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1232247A4 Modulation of signal transduction
06/18/2003EP1228075B1 Silicon compounds derived from ascorbic acid
06/18/2003EP1225898B1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
06/18/2003EP1202999B1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs
06/18/2003EP1200317B1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
06/18/2003EP1171578B1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
06/18/2003EP1171128B1 Combination of n-butyldeoxynojirimycin (nb-dnj) and glycolipid degrading enzymes in therapy
06/18/2003EP1168920B1 (s)-enantiomer enriched fipronil composition
06/18/2003EP1140829A4 Contrast media for angiography
06/18/2003EP1135401B1 Glyceryl nucleotides, method for the production thereof and their use
06/18/2003EP1115704B1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
06/18/2003EP1102747B1 Crystalline forms of osanetant
06/18/2003EP1098874B1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
06/18/2003EP1077984B1 2"-deoxy hygromycin derivatives
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1056737B1 Process for the preparation of simvastatin and derivatives thereof
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP0981338B1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
06/18/2003EP0936902B1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
06/18/2003EP0907631B1 Inorganic ion receptor-active compounds
06/18/2003EP0868177B1 Drug delivery device
06/18/2003EP0827498B1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
06/18/2003EP0821588B1 Levobupivacaine and its use as an anaesthetic in pregnant women
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003EP0815859B1 Intimal thickening inhibitors
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/18/2003EP0749423B1 Piperidines and pyrrolidines
06/18/2003EP0650377B1 Neuroinhibitory compounds released by implanting devices
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425021A Gallotannins and ellagitannins as regulators of cytokine release
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1425007A Preparation of sulfonamides
06/18/2003CN1425005A Cyclic quaternary ammonium compound
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
1 ... 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 ... 7860